- Home
- AEYE vs FBIO Comparison
AEYE vs FBIO Comparison
Compare AEYE & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AEYE | FBIO |
|---|---|---|
| Founded | 2005 | 2006 |
| Country | United States | United States |
| Employees | N/A | 78 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.9M | 78.3M |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | AEYE | FBIO |
|---|---|---|
| Price | $7.16 | $2.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $14.63 | ★ $17.00 |
| AVG Volume (30 Days) | 174.1K | ★ 419.6K |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 30.56 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $40,311,000.00 | N/A |
| Revenue This Year | $11.12 | $55.22 |
| Revenue Next Year | $11.45 | $40.55 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 14.52 | N/A |
| 52 Week Low | $5.31 | $1.62 |
| 52 Week High | $16.39 | $4.53 |
Technical Indicators
Market Signals| Indicator | AEYE | FBIO |
|---|---|---|
| Relative Strength Index (RSI) | 58.03 | 32.23 |
| Support Level | $6.35 | $2.20 |
| Resistance Level | $7.42 | $2.49 |
| Average True Range (ATR) | 0.38 | 0.10 |
| MACD | 0.06 | 0.02 |
| Stochastic Oscillator | 81.09 | 0.48 |
Price Performance
Historical ComparisonAbout AEYE AudioEye Inc.
AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. Trusted by the ADP, Tommy Hilfiger, A360 Media, Samsung, Landry's and others. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.